The Serum Institute of India, which is manufacturing and testing the Oxford / AstraZeneca coronavirus vaccine in the country, said Monday. awaited regulatory approval to take in a few days. Serum CEO Adar Poonawalla said the vaccine, called Covishield in India, should be licensed by January. “The emergency use authorization …
Read More »Why the storage and distribution of Covid-19 vaccines will be the next challenge
Written by Abhishek De, edited by Explained Desk | New Delhi | Updated: October 21, 2020 2:10:25 pm A health worker takes a swab sample for Covid-19 testing in New Delhi (Express photo by Praveen Khanna) We can have a Covid-19 vaccine for this year itself, with some eight candidates …
Read More »India expects to vaccinate 20-25 million million people by July next year
By: Desk Explained | Pune | Updated: October 6, 2020 9:21:50 am Travelers wearing masks wait at a traffic intersection in Kochi, Kerala (AP) Coronavirus Vaccine Tracker: India is working to vaccinate 20 to 25 million million of its population, about one sixth of its total population, against Covid19 disease …
Read More »Oxford University’s Covid-19 Vaccine Could Be Implemented in Six Months
By: PTI | London | Updated: October 3, 2020 10:31:51 pm The candidate vaccine tested by scientists at the University of Oxford in collaboration with the pharmaceutical giant AstraZeneca is the most advanced in the testing process and, according to a report by “The Times” There is growing hope that …
Read More »1.2 billion doses of Russian vaccine reserved
By: Desk Explained | Pune | Updated: September 22, 2020 9:16:23 am Moscow: An injection of Russia’s experimental Sputnik V coronavirus vaccine is shown before use in Moscow, Russia (AP) Coronavirus Vaccine Tracker: At least ten countries in Asia, South America and the Middle East have signed agreements to access …
Read More »